LCAT_HUMAN - dbPTM
LCAT_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LCAT_HUMAN
UniProt AC P04180
Protein Name Phosphatidylcholine-sterol acyltransferase
Gene Name LCAT
Organism Homo sapiens (Human).
Sequence Length 440
Subcellular Localization Secreted . Secreted into blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Produced in astrocytes and secreted into cerebral spinal fluid (CSF).
Protein Description Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs). [PubMed: 10329423]
Protein Sequence MGPPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
44N-linked_GlycosylationTPKAELSNHTRPVIL
CCCHHHCCCCCCEEE
53.8517623646
44N-linked_GlycosylationTPKAELSNHTRPVIL
CCCHHHCCCCCCEEE
53.8516335952
108N-linked_GlycosylationDNTRVVYNRSSGLVS
CCCEEEEECCCCCCC
26.2526195816
108N-linked_GlycosylationDNTRVVYNRSSGLVS
CCCEEEEECCCCCCC
26.2526195816
205PhosphorylationPVFLIGHSLGCLHLL
CEEEEEHHHHHHHHH
22.6522817900
213PhosphorylationLGCLHLLYFLLRQPQ
HHHHHHHHHHHHCCH
9.88-
296N-linked_GlycosylationFISTPSFNYTGRDFQ
EEECCCCCCCCHHHH
37.4826195816
296N-linked_GlycosylationFISTPSFNYTGRDFQ
EEECCCCCCCCHHHH
37.4826195816
376PhosphorylationDDTVATRSTELCGLW
CCCEEEECHHCCCCC
23.14-
377PhosphorylationDTVATRSTELCGLWQ
CCEEEECHHCCCCCC
29.68-
408N-linked_GlycosylationHLNMVFSNLTLEHIN
HHHHHHCCCCHHHHH
26.1126195816
408N-linked_GlycosylationHLNMVFSNLTLEHIN
HHHHHHCCCCHHHHH
26.1126195816
431O-linked_GlycosylationQGPPASPTASPEPPP
CCCCCCCCCCCCCCC
36.957613477
431O-linked_GlycosylationQGPPASPTASPEPPP
CCCCCCCCCCCCCCC
36.957613477
433O-linked_GlycosylationPPASPTASPEPPPPE
CCCCCCCCCCCCCCC
32.077613477
433O-linked_GlycosylationPPASPTASPEPPPPE
CCCCCCCCCCCCCCC
32.077613477

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of LCAT_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
431TGlycosylation

7613477
433SGlycosylation

7613477

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
115N-linked Glycosylation123 (8)RHrs199717050
  • Total cholesterol levels in HDL
29084231

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
APOA1_HUMANAPOA1physical
4335615
APOA1_HUMANAPOA1physical
10222237
APOA1_HUMANAPOA1physical
15654758
APOE_HUMANAPOEphysical
15654758
APOA1_HUMANAPOA1physical
10026251
FYV1_HUMANPIKFYVEphysical
26195816

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
245900Lecithin-cholesterol acyltransferase deficiency (LCATD)
136120Fish-eye disease (FED)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LCAT_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-44 AND ASN-296, AND MASSSPECTROMETRY.
"Site-specific detection and structural characterization of theglycosylation of human plasma proteins lecithin:cholesterolacyltransferase and apolipoprotein D using HPLC/electrospray massspectrometry and sequential glycosidase digestion.";
Schindler P.A., Settineri C.A., Collet X., Fielding C.J.,Burlingame A.L.;
Protein Sci. 4:791-803(1995).
Cited for: GLYCOSYLATION AT ASN-44; ASN-108; ASN-296; ASN-408; THR-431 ANDSER-433, STRUCTURE OF CARBOHYDRATES, AND MASS SPECTROMETRY.
O-linked Glycosylation
ReferencePubMed
"Site-specific detection and structural characterization of theglycosylation of human plasma proteins lecithin:cholesterolacyltransferase and apolipoprotein D using HPLC/electrospray massspectrometry and sequential glycosidase digestion.";
Schindler P.A., Settineri C.A., Collet X., Fielding C.J.,Burlingame A.L.;
Protein Sci. 4:791-803(1995).
Cited for: GLYCOSYLATION AT ASN-44; ASN-108; ASN-296; ASN-408; THR-431 ANDSER-433, STRUCTURE OF CARBOHYDRATES, AND MASS SPECTROMETRY.

TOP